These findings not only deepen our understanding of the molecular mechanisms driving chemotherapy resistance but also propose ATR inhibition as a viable approach to improve treatment efficacy in PAK6-high gastric cancers [109]. The gene discussed is ATR; the disease is gastric cancer.